U Penn researchers find that mutated ATRX gene linked to brain tumors is a potential biomarker for rare adrenal tumors too

For the first time, researchers at Penn’s Abramson Cancer Center have found that a mutation in the ATRX may serve as a much-needed biomarker for the pheochromocytomas and paragangliomas that become malignant. …read more

Source:: Cancer